Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 172

Results For "report"

1819 News Found

INNOVIO QoQ revenues down for the period ended June 30, 2021
Biotech | August 10, 2021

INNOVIO QoQ revenues down for the period ended June 30, 2021

Company working on COVID vaccine INO 4800


Advanced Enzyme Technologies Q1FY22 consolidated PAT up at Rs. 38.04 cr
News | August 09, 2021

Advanced Enzyme Technologies Q1FY22 consolidated PAT up at Rs. 38.04 cr

The company posted net profit of Rs.34.24 crores for the period ended June 30, 2020.


China NMPA approves phase II clinical trial of ASC40
Policy | August 09, 2021

China NMPA approves phase II clinical trial of ASC40

Phase II trial will evaluate the safety and efficacy of ASC40 in patients with moderate to severe acne


AstraZeneca Pharma India PAT at Rs 10.24 crores
Biotech | August 09, 2021

AstraZeneca Pharma India PAT at Rs 10.24 crores

Board declares interim dividend of Rs 2 per equity share


Centre releases Rs. 60 crore to states seeking grants to tackle the Sickle Cell Anaemia
Policy | August 09, 2021

Centre releases Rs. 60 crore to states seeking grants to tackle the Sickle Cell Anaemia

Sickle Cell Disease Support Corner developed to create a database of individuals with sickle cell disease


Alkem Laboratories PAT at Rs 468.12 crore for Q1FY22
News | August 08, 2021

Alkem Laboratories PAT at Rs 468.12 crore for Q1FY22

EPS stood at Rs 39.15


Metropolis Healthcare PAT at Rs 74.89 crores for Q1FY22
Healthcare | August 08, 2021

Metropolis Healthcare PAT at Rs 74.89 crores for Q1FY22

Board approves fundraise of Rs 1500 crore


Abbott India net profit rises to 8.5 per cent in Q1FY22
News | August 08, 2021

Abbott India net profit rises to 8.5 per cent in Q1FY22

PAT rises to Rs 195.76 crore


Cipla posts  net profit at Rs 715 crores
News | August 08, 2021

Cipla posts net profit at Rs 715 crores

India business contributes to a stellar performance


Divi's Labs posts a 13 per cent rise in PAT at Rs 557.11 crore
News | August 08, 2021

Divi's Labs posts a 13 per cent rise in PAT at Rs 557.11 crore

Forex gains stood at Rs 20 crore for the quarter